Full video transcriptClick to expand
Auto-generated transcript of @iamzezu's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00You see this supplement right here this supplement right here
- 0:05No, baby. No
- 0:07Never never ever again. I finally had reversed my PCS symptoms
- 0:11And then I decided to add
- 0:13Burberry because apparently it will increase your GLP one it will make you lose weight it will make you crave less crave less
- 0:22GelP1 increase is more like a decrease and I'm like a vacuum like I would eat everything
- 0:26Onceing to eat everything seriously it my period is completely out of whack
- 0:34The recitism or however you pronounce it is back and oh my god. I wish I've never taken this
- 0:41Never
- 0:42It's so bad like it's so bad. I'm happy for for for whoever it's working
- 0:47But I'm so angry like I gave it a try before and I was like nah and then I tried it again
- 0:54And I'm just like why did I do this?
- 0:56Why?
Berberine for PCOS weight loss: what the evidence actually shows
Quick answer
The creator reports using berberine as a GLP-1 potentiator for PCOS management, then experiencing increased appetite, menstrual irregularity, and return of hirsutism. While berberine has demonstrated modest GLP-1 stimulation and insulin-sensitizing effects in small trials, its hormonal effects in PCOS are inconsistent across individuals, and it lacks the regulatory review required to establish safety and efficacy for this use. Anyone managing PCOS hormonally should disclose all supplements to their prescribing clinician, particularly if taking insulin sensitizers or any GLP-1 receptor agonist.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Berberine for PCOS weight loss: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Berberine for PCOS weight loss: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Berberine for PCOS weight loss: what the evidence actually shows" from Zezu | زيزو ✨. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports using berberine as a GLP-1 potentiator for PCOS management, then experiencing increased appetite, menstrual irregularity, and return of hirsutism.
The reason this review is not generic is the source wording and the canonical claim label "glp1 and here we go starting all over again pcos berberine weight." In this clip, the useful excerpt is: "You see this supplement right here this supplement right here No, baby." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator reports using berberine as a GLP-1 potentiator for PCOS management, then experiencing increased appetite, menstrual irregularity, and return of hirsutism.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator reports using berberine as a GLP-1 potentiator for PCOS management, then experiencing increased appetite, menstrual irregularity, and return of hirsutism. While berberine has demonstrated modest GLP-1 stimulation and insulin-sensitizing effects in small trials, its hormonal effects in PCOS are inconsistent across individuals, and it lacks the regulatory review required to establish safety and efficacy for this use. Anyone managing PCOS hormonally should disclose all supplements to their prescribing clinician, particularly if taking insulin sensitizers or any GLP-1 receptor agonist.
- Berberine stimulates GLP-1 secretion in intestinal cells (Ye et al., 2021), but its mechanism and potency are not comparable to FDA-reviewed GLP-1 receptor agonists like semaglutide or tirzepatide.
- A 2012 randomized trial (An et al., Fertility and Sterility) found berberine improved menstrual cycles in PCOS patients, which makes the creator's opposite experience notable but not impossible given individual variation.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Berberine stimulates GLP-1 secretion in intestinal cells (Ye et al., 2021), but its mechanism and potency are not comparable to FDA-reviewed GLP-1 receptor agonists like semaglutide or tirzepatide.
- A 2012 randomized trial (An et al., Fertility and Sterility) found berberine improved menstrual cycles in PCOS patients, which makes the creator's opposite experience notable but not impossible given individual variation.
- Berberine is an unregulated supplement. Purity, dosage accuracy, and formulation quality vary significantly between brands, which affects both efficacy and safety.
- Combining berberine with a prescription GLP-1 receptor agonist has not been adequately studied. Stacking these without clinician oversight is not recommended.
- PCOS symptom improvement, including menstrual regularity and androgen-related symptoms, involves multiple hormonal axes. Attributing changes solely to one supplement addition requires clinical labs, not just self-observation.
- Small trial sizes and short durations limit what we can conclude about berberine in PCOS. Most positive studies involve controlled conditions that differ significantly from typical supplement use.
- Anyone managing PCOS with hormonal or metabolic treatments should disclose all supplements to their prescriber, since berberine interacts with insulin sensitivity, androgen metabolism, and gut signaling pathways.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @iamzezu actually say?
The creator says berberine, which they were taking because it supposedly "increases your GLP-1" and reduces cravings, did the opposite for them. Their words: "I'm like a vacuum, like I would eat everything." They also report their period going "completely out of whack" and the return of hirsutism. They had previously reversed their PCOS symptoms before adding berberine, and they're now ditching it entirely.
This is an anecdotal account, not a clinical report. But the specific mechanisms they're describing, GLP-1 signaling, hunger regulation, and hormonal disruption in PCOS, are real pharmacological territory worth examining seriously. Personal experience on social media can't prove causation, but it can raise legitimate questions that the evidence should answer.
Does the science back the GLP-1 claim?
Partially, but the picture is more complicated than TikTok makes it look. Yes, berberine has shown GLP-1 activity in some studies. No, that does not mean it will suppress appetite the way semaglutide or tirzepatide does for every person who takes it.
A 2021 paper by Ye et al. in Frontiers in Pharmacology found berberine can stimulate GLP-1 secretion from intestinal L-cells. A 2012 randomized trial by Zhang et al. in Metabolism showed berberine improved insulin sensitivity and lipid profiles in type 2 diabetes patients. These are real findings. However, the magnitude of GLP-1 elevation from berberine is modest and indirect compared to actual GLP-1 receptor agonists. Calling berberine "nature's Ozempic" is a marketing leap, not a pharmacological equivalency. The mechanisms are not the same, the receptor binding is not the same, and the clinical outcomes are not reliably the same.
For PCOS specifically, a 2012 study by An et al. in Fertility and Sterility found berberine improved menstrual cyclicity in PCOS patients. So the creator's experience of menstrual disruption runs counter to what that trial found. Individual variation is real, and that trial was small.
What did they get wrong, or right?
They got the core mechanism roughly right: berberine does appear to influence GLP-1 pathways. Credit for that. Where the framing gets loose is in assuming that GLP-1 increase automatically equals appetite suppression for everyone. That is not how this works.
GLP-1 receptor agonists used in clinical settings work through sustained, high-level receptor activation. Berberine produces a more diffuse metabolic effect. The creator says the GLP-1 increase "is more like a decrease" in their experience. That framing is confused, but their underlying observation, that they felt hungrier, not less hungry, is plausible given that berberine also affects gut motility, bile acid metabolism, and the gut microbiome in ways that could, in some individuals, increase appetite-related signaling rather than suppress it.
The return of hirsutism and menstrual irregularity is harder to attribute directly to berberine without labs. Other factors, including stress, caloric changes, and sleep, all affect PCOS symptoms. Still, berberine does interact with androgen metabolism via its effects on SHBG and insulin, so a hormonal response is not implausible.
What should you actually know?
Berberine is not a regulated pharmaceutical. It is sold as a supplement, which means dosing, purity, and formulation vary widely between products. If you have PCOS and are considering berberine, the first conversation needs to happen with your endocrinologist or OB-GYN, not TikTok.
Individual response to berberine varies significantly. Studies showing benefit are generally small, short-term, and conducted in specific populations. A study working for women with insulin-resistant PCOS on a controlled diet is not the same as your situation.
If you are already on a GLP-1 receptor agonist, adding berberine without medical supervision is not a safe stack. The combined effects on GLP-1 signaling, gut motility, and blood glucose have not been studied adequately in combination. Do not layer these without a prescriber's input.
The creator's frustration is valid. They tried something based on social media advice, it disrupted progress they had worked hard for, and now they are starting over. That is a real cost. It is also a reason to be skeptical of supplement claims that borrow the language of FDA-reviewed medications without the evidence base to back it up.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Zezu | زيزو ✨ · TikTok creator
127.4K views on this video
And here we go starting all over again 😢! #pcos #berberine #weightloss #pcosproblems #pcoslife
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about berberine stimulates glp-1 secretion in intestinal cells (ye et al.,?
Berberine stimulates GLP-1 secretion in intestinal cells (Ye et al., 2021), but its mechanism and potency are not comparable to FDA-reviewed GLP-1 receptor agonists like semaglutide or tirzepatide.
What does the video say about a 2012 randomized trial (an et al., fertility?
A 2012 randomized trial (An et al., Fertility and Sterility) found berberine improved menstrual cycles in PCOS patients, which makes the creator's opposite experience notable but not impossible given individual variation.
What does the video say about berberine?
Berberine is an unregulated supplement. Purity, dosage accuracy, and formulation quality vary significantly between brands, which affects both efficacy and safety.
What does the video say about combining berberine with a prescription glp-1 receptor agonist has not?
Combining berberine with a prescription GLP-1 receptor agonist has not been adequately studied. Stacking these without clinician oversight is not recommended.
What does the video say about pcos symptom improvement, including menstrual regularity?
PCOS symptom improvement, including menstrual regularity and androgen-related symptoms, involves multiple hormonal axes. Attributing changes solely to one supplement addition requires clinical labs, not just self-observation.
What does the video say about small trial sizes?
Small trial sizes and short durations limit what we can conclude about berberine in PCOS. Most positive studies involve controlled conditions that differ significantly from typical supplement use.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Zezu | زيزو ✨, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.